Showing results (41-50 of 90) with videos related to

Sort By:
Pageof 9
Pathology International|October 17, 2006
Immunohistochemical study of the relationship between Ki-67 labeling index of proliferating cells of gynecomastia, histological phase and duration of diseaseSeishi Kono, Masafumi Kurosumi, Hanako Simooka, et al.
Investigational New Drugs|March 9, 2019
Eribulin, trastuzumab, and pertuzumab as first-line therapy for patients with HER2-positive metastatic breast cancer: a phase II, multicenter, collaborative, open-label, single-arm clinical trialKenichi Inoue, Jun Ninomiya, Tsuyoshi Saito, et al.
BMC Research Notes|July 9, 2013
Paclitaxel-resistant advanced recurrent breast cancer: a case of partial response due to addition of bevacizumab to paclitaxel therapy: a case reportKazuo Ishizuna, Jun Ninomiya, Makoto Kojima, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 12, 2014
Locally advanced breast cancer with bleeding - two cases effectively treated with bevacizumab plus weekly paclitaxelKazuo Ishizuna, Jun Ninomiya, Toshihisa Ogawa, et al.
The Journal of Biological Chemistry|May 6, 2006
TAK1 is a master regulator of epidermal homeostasis involving skin inflammation and apoptosisEmily Omori, Kunihiro Matsumoto, Hideki Sanjo, et al.
EMBO Reports|January 30, 2004
Involvement of ASK1 in Ca2+-induced p38 MAP kinase activationKohsuke Takeda, Atsushi Matsuzawa, Hideki Nishitoh, et al.
International Immunology|August 31, 2006
TAK1 is indispensable for development of T cells and prevention of colitis by the generation of regulatory T cellsShintaro Sato, Hideki Sanjo, Tohru Tsujimura, et al.
Oncology Reports|June 7, 2003
Prognostic significance of scoring system based on histological heterogeneity of invasive ductal carcinoma for node-negative breast cancer patientsMasafumi Kurosumi, Toshio Tabei, Kenichi Inoue, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2008
Enterocyte-derived TAK1 signaling prevents epithelium apoptosis and the development of ileitis and colitisRie Kajino-Sakamoto, Maiko Inagaki, Elisabeth Lippert, et al.
The Breast Journal|September 9, 2006
Sentinel lymph node biopsy alone has no adverse impact on the survival of patients with breast cancerHiroyuki Takei, Kimito Suemasu, Masafumi Kurosumi, et al.
Pageof 9